152 related articles for article (PubMed ID: 30567502)
1. Seroprevalence of measles vaccine antibody response in vertically HIV-infected children, in Morocco.
Haban H; Benchekroun S; Sadeq M; Tajounte L; Ahmed HJ; Benjouad A; Amzazi S; Oumzil H; Elharti E
BMC Infect Dis; 2018 Dec; 18(1):680. PubMed ID: 30567502
[TBL] [Abstract][Full Text] [Related]
2. Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.
Rainwater-Lovett K; Nkamba HC; Mubiana-Mbewe M; Bolton-Moore C; Moss WJ
J Infect Dis; 2013 Dec; 208(11):1747-55. PubMed ID: 23911708
[TBL] [Abstract][Full Text] [Related]
3. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
Jallow S; Cutland CL; Masbou AK; Adrian P; Madhi SA
J Clin Virol; 2017 Sep; 94():50-56. PubMed ID: 28759772
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.
Haban H; Benchekroun S; Sadeq M; Benjouad A; Amzazi S; Oumzil H; Elharti E
BMC Public Health; 2017 Sep; 17(1):752. PubMed ID: 28962610
[TBL] [Abstract][Full Text] [Related]
5. Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children.
Mutsaerts EAML; Nunes MC; van Rijswijk MN; Klipstein-Grobusch K; Otwombe K; Cotton MF; Violari A; Madhi SA
Clin Infect Dis; 2019 Aug; 69(4):687-696. PubMed ID: 30418528
[TBL] [Abstract][Full Text] [Related]
6. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ
Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of transplacentally acquired measles antibodies in HIV-exposed versus HIV-unexposed infants at six months of age.
Jain S; Seth A; Khare S; Chandra J
Indian J Med Res; 2017 Apr; 145(4):536-542. PubMed ID: 28862187
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to measles immunization and the impacts on HIV-infected children.
Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of measles IgG among HIV-1-infected and uninfected Kenyan adults.
Merkel M; Ben-Youssef L; Newman LP; Gitome V; Gataguta A; Lohman-Payne B; Bosire R; Farquhar C
Int J Infect Dis; 2014 Feb; 19():103-5. PubMed ID: 24334025
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.
Nair N; Moss WJ; Scott S; Mugala N; Ndhlovu ZM; Lilo K; Ryon JJ; Monze M; Quinn TC; Cousens S; Cutts F; Griffin DE
J Infect Dis; 2009 Oct; 200(7):1031-8. PubMed ID: 19702505
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco].
Caidi H; Bennis IF; Mouan N; El Aouad R
East Mediterr Health J; 2004; 10(4-5):474-81. PubMed ID: 16335637
[TBL] [Abstract][Full Text] [Related]
14. Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review.
Loevinsohn G; Rosman L; Moss WJ
Clin Infect Dis; 2019 Aug; 69(5):836-844. PubMed ID: 30452621
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
Moss WJ; Scott S; Mugala N; Ndhlovu Z; Beeler JA; Audet SA; Ngala M; Mwangala S; Nkonga-Mwangilwa C; Ryon JJ; Monze M; Kasolo F; Quinn TC; Cousens S; Griffin DE; Cutts FT
J Infect Dis; 2007 Aug; 196(3):347-55. PubMed ID: 17597448
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.
Chandwani S; Beeler J; Li H; Audet S; Smith B; Moye J; Nalin D; Krasinski K;
J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S179-89. PubMed ID: 21666159
[TBL] [Abstract][Full Text] [Related]
17. Measles seroprevalence and vaccine response in HIV-infected adults.
Wallace MR; Hooper DG; Graves SJ; Malone JL
Vaccine; 1994 Oct; 12(13):1222-4. PubMed ID: 7839728
[TBL] [Abstract][Full Text] [Related]
18. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
al-Attar I; Reisman J; Muehlmann M; McIntosh K
Pediatr Infect Dis J; 1995 Feb; 14(2):149-51. PubMed ID: 7746699
[No Abstract] [Full Text] [Related]
19. Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998.
Loo MK; Sabahi F; Soleimanjdahi H; Kazemnejad A; Roustai MH
Eur J Epidemiol; 2003; 18(11):1085-9. PubMed ID: 14620944
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.
Farquhar C; Wamalwa D; Selig S; John-Stewart G; Mabuka J; Majiwa M; Sutton W; Haigwood N; Wariua G; Lohman-Payne B
Pediatr Infect Dis J; 2009 Apr; 28(4):295-9. PubMed ID: 19258919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
